チャペロン媒介による自は,胚幹細胞の多能性を調節する
Yi Xu1, Yang Zhang1, Juan C García-Cañaveras2
1Department of Cancer Biology and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
まとめ
胚性幹細胞は Chaperone-mediated autophagy (CMA) を抑制することで多能性を維持する. 減少したCMAは自己再生を促し,増加したCMAは代謝と表遺伝子調節に影響することで分化を促進する.
科学分野:
- 幹細胞生物学
- 分子生物学と細胞生物学
- エピジェネティクス
背景:
- 胚性幹細胞 (ESC) は無限の自己再生と分化能力を持っています.
- ESCの多能性を維持する分子メカニズムは完全に理解されていません.
研究 の 目的:
- ESCの多能性の維持におけるチャペロン媒介の自己消化 (CMA) の役割を調査する.
- プラリポテンシー因子,CMA,代謝,および表遺伝的調節との関連を解明する.
主な方法:
- 経済委員会におけるCMA活動の分析
- 核多能性因子OCT4とSOX2に対するCMAの影響の調査
- 細胞内α-ケトグルタレート濃度の測定
- ヒストンとDNAデメチラーゼの活性度の評価
主要な成果:
- 核の多能性因子OCT4とSOX2は,ESCにおけるチャペロン媒介の自己消化 (CMA) を抑制する.
- 低CMA活動は,ESCの自己更新に不可欠であり,高CMAは差別化を促します.
- CMAはイソチラート脱水酵素 (IDH1/IDH2) を分解し,α-ケトグルタレットのレベルを低下させます.
- 減少したα-ケトグルタレットはヒストンとDNAデメチラゼに影響を与え,表遺伝的状況に影響を与えます.
結論:
- CMAは,ESCの多能性と差別化の重要なレギュレータとして機能します.
- OCT4とSOX2は,CMA,代謝,および表遺伝子を調節することによってESCの運命を制御します.
- この研究は,オートファギーを幹細胞の運命決定に結びつける新しい経路を明らかにしています.
関連する概念動画
Maintenance of the ES Cell State
2.6K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.6K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Somatic to iPS Cell Reprogramming
2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K
The Spindle Assembly Checkpoint
3.6K
The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.6K
Methods of Nuclear Reprogramming
2.0K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.0K
Induced Pluripotent Stem Cells
26.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
26.8K


